Difficulty: Medium
Average Score: 93%
Practice
Glucocorticosteroids inhibit:
Correct answer
C
Rationale
Glucocorticosteroids, such as cortisone and prednisone, are known to inhibit the synthesis of leukotrienes C4 and D4. These medications act by suppressing the enzyme phospholipase A2, which is responsible for releasing arachidonic acid from cell membranes. Arachidonic acid is then converted into leukotrienes via the lipoxygenase pathway. By inhibiting this pathway, glucocorticosteroids reduce inflammation and immune responses.
Option A, platelet thromboxane A2 synthesis, is not inhibited by glucocorticosteroids. Thromboxane A2 is derived from arachidonic acid through the cyclooxygenase pathway, which is not directly affected by these medications.
Option B, histamine release, is also not directly inhibited by glucocorticosteroids. Histamine is stored in mast cells and basophils and is released in response to various stimuli, but glucocorticosteroids primarily target the arachidonic acid pathway to exert their anti-inflammatory effects.
Option D, arachidonic acid metabolism, may seem like a reasonable choice, but glucocorticosteroids actually modulate the metabolism of arachidonic acid by inhibiting the formation of leukotrienes rather than directly affecting the metabolism of arachidonic acid itself.
Understanding the mechanisms of action of glucocorticosteroids in inhibiting specific inflammatory mediators like leukotrienes is crucial in clinical settings when managing conditions such as asthma, rheumatoid arthritis, and other inflammatory disorders. By grasping the targeted pathways of these drugs, healthcare professionals can make informed decisions regarding their use and potential side effects.
Option A, platelet thromboxane A2 synthesis, is not inhibited by glucocorticosteroids. Thromboxane A2 is derived from arachidonic acid through the cyclooxygenase pathway, which is not directly affected by these medications.
Option B, histamine release, is also not directly inhibited by glucocorticosteroids. Histamine is stored in mast cells and basophils and is released in response to various stimuli, but glucocorticosteroids primarily target the arachidonic acid pathway to exert their anti-inflammatory effects.
Option D, arachidonic acid metabolism, may seem like a reasonable choice, but glucocorticosteroids actually modulate the metabolism of arachidonic acid by inhibiting the formation of leukotrienes rather than directly affecting the metabolism of arachidonic acid itself.
Understanding the mechanisms of action of glucocorticosteroids in inhibiting specific inflammatory mediators like leukotrienes is crucial in clinical settings when managing conditions such as asthma, rheumatoid arthritis, and other inflammatory disorders. By grasping the targeted pathways of these drugs, healthcare professionals can make informed decisions regarding their use and potential side effects.